Anika Therapeutics (ANIK) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Anika Therapeutics Revenue Highlights

Latest Revenue (Y)

$112.82M

Latest Revenue (Q)

$29.61M

Main Segment (Y)

Joint Preservation and Restoration

Main Geography (Y)

UNITED STATES

Anika Therapeutics Revenue by Period

Anika Therapeutics Revenue by Year

Date	Revenue	Change
2025-12-31	$112.82M	-5.91%
2024-12-31	$119.91M	-0.73%
2023-12-31	$120.79M	6.12%
2022-12-31	$113.83M	-22.98%
2021-12-31	$147.79M	13.29%
2020-12-31	$130.46M	13.83%
2019-12-31	$114.61M	8.58%
2018-12-31	$105.56M	-6.93%
2017-12-31	$113.42M	9.71%
2016-12-31	$103.38M	11.16%
2015-12-31	$93.00M	-11.93%
2014-12-31	$105.59M	40.64%
2013-12-31	$75.08M	5.22%
2012-12-31	$71.36M	10.16%
2011-12-31	$64.78M	16.60%
2010-12-31	$55.56M	38.42%
2009-12-31	$40.14M	12.17%
2008-12-31	$35.78M	16.06%
2007-12-31	$30.83M	14.86%
2006-12-31	$26.84M	-10.04%
2005-12-31	$29.84M	12.73%
2004-12-31	$26.47M	71.81%
2003-12-31	$15.40M	16.81%
2002-12-31	$13.19M	16.57%
2001-12-31	$11.31M	-30.75%
2000-12-31	$16.34M	21.00%
1999-12-31	$13.50M	-2.88%
1998-12-31	$13.90M	15.83%
1997-12-31	$12.00M	900.00%
1996-12-31	$1.20M	-64.71%
1995-08-31	$3.40M	-27.66%
1994-08-31	$4.70M	113.64%
1993-08-31	$2.20M	-

Anika Therapeutics generated $112.82M in revenue during NA 2025, up -5.91% compared to the previous quarter, and up 86.48% compared to the same period a year ago.

Anika Therapeutics Revenue by Quarter

Date	Revenue	Change
2026-03-31	$29.61M	-3.28%
2025-12-31	$30.61M	10.06%
2025-09-30	$27.82M	-1.42%
2025-06-30	$28.22M	7.84%
2025-03-31	$26.17M	-2128.53%
2024-12-31	$-1.29M	-103.33%
2024-09-30	$38.75M	26.13%
2024-06-30	$30.72M	-24.18%
2024-03-31	$40.52M	-5.70%
2023-12-31	$42.97M	3.63%
2023-09-30	$41.47M	-6.40%
2023-06-30	$44.30M	16.82%
2023-03-31	$37.92M	-4.29%
2022-12-31	$39.62M	-1.59%
2022-09-30	$40.26M	1.53%
2022-06-30	$39.66M	8.08%
2022-03-31	$36.69M	2.43%
2021-12-31	$35.82M	-9.40%
2021-09-30	$39.54M	3.65%
2021-06-30	$38.15M	11.24%
2021-03-31	$34.29M	4.91%
2020-12-31	$32.69M	3.14%
2020-09-30	$31.69M	3.31%
2020-06-30	$30.68M	-13.33%
2020-03-31	$35.40M	18.89%
2019-12-31	$29.77M	0.25%
2019-09-30	$29.70M	-2.37%
2019-06-30	$30.42M	23.04%
2019-03-31	$24.72M	-8.28%
2018-12-31	$26.96M	0.63%
2018-09-30	$26.79M	-12.31%
2018-06-30	$30.55M	43.66%
2018-03-31	$21.26M	-27.64%
2017-12-31	$29.39M	8.11%
2017-09-30	$27.18M	-18.76%
2017-06-30	$33.46M	43.09%
2017-03-31	$23.39M	-18.59%
2016-12-31	$28.73M	11.39%
2016-09-30	$25.79M	-2.98%
2016-06-30	$26.58M	19.29%
2016-03-31	$22.28M	-27.87%
2015-12-31	$30.89M	30.46%
2015-09-30	$23.68M	3.40%
2015-06-30	$22.90M	47.57%
2015-03-31	$15.52M	-33.26%
2014-12-31	$23.25M	5.44%
2014-09-30	$22.06M	-16.06%
2014-06-30	$26.27M	-22.74%
2014-03-31	$34.01M	60.04%
2013-12-31	$21.25M	19.70%
2013-09-30	$17.75M	-14.76%
2013-06-30	$20.83M	36.61%
2013-03-31	$15.25M	-32.55%
2012-12-31	$22.61M	53.09%
2012-09-30	$14.77M	-24.76%
2012-06-30	$19.62M	36.66%
2012-03-31	$14.36M	-22.14%
2011-12-31	$18.44M	-0.06%
2011-09-30	$18.46M	14.34%
2011-06-30	$16.14M	37.51%
2011-03-31	$11.74M	-20.27%
2010-12-31	$14.72M	6.15%
2010-09-30	$13.87M	-4.35%
2010-06-30	$14.50M	16.31%
2010-03-31	$12.47M	17.39%
2009-12-31	$10.62M	-1.61%
2009-09-30	$10.79M	13.33%
2009-06-30	$9.52M	3.51%
2009-03-31	$9.20M	2.62%
2008-12-31	$8.97M	-2.60%
2008-09-30	$9.21M	1.60%
2008-06-30	$9.06M	5.98%
2008-03-31	$8.55M	-11.20%
2007-12-31	$9.63M	-

Anika Therapeutics generated $29.61M in revenue during Q1 2026, up -3.28% compared to the previous quarter, and up -2295.50% compared to the same period a year ago.

Anika Therapeutics Revenue Breakdown

Anika Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Non-Orthopedic	$9.86M	$7.95M	$9.70M	-	-
Joint Preservation and Restoration	$54.88M	$50.40M	$48.59M	$39.37M	-
OA Pain Management	-	$97.89M	$89.50M	-	-
Product	-	-	$147.79M	$130.46M	$114.51M
Licensing, Milestone and Contract Revenue	-	-	-	-	-
Joint Pain Management Therapies	-	-	-	$83.03M	-
Manufactured Product, Other	-	-	-	$8.06M	$6.08M
Surgical	-	-	-	-	$5.18M
Dermal	-	-	-	-	$2.24M
Orthobiologics	-	-	-	-	$101.00M

Anika Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Joint Preservation and Restoration (84.77%), and Non-Orthopedic (15.23%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Joint Preservation and Restoration	$11.95M	$13.84M	$15.30M	$13.47M	$12.66M	$13.45M	$14.35M	$11.82M	$12.10M	$12.14M	$13.29M	$11.19M	$11.88M	$12.22M	-	-	-	-	-	-
Non-Orthopedic	$2.38M	$2.36M	$2.60M	$3.11M	$2.31M	$1.84M	$1.53M	$2.78M	$1.82M	$1.82M	-	-	-	-	-	-	-	-	-	-
OA Pain Management	-	-	-	-	$29.33M	$22.63M	$23.75M	$25.66M	$25.74M	$22.73M	-	-	-	-	-	-	-	-	-	-
Product	-	-	-	-	-	-	-	-	-	$36.69M	$35.82M	$39.54M	$38.15M	$34.29M	$32.69M	$31.69M	$30.68M	$35.40M	$29.77M	$29.61M
Manufactured Product, Other	-	-	-	-	-	-	-	-	-	-	-	$2.19M	$1.94M	$2.76M	$2.69M	$1.54M	$1.81M	$2.02M	$1.37M	$1.85M
Joint Pain Management Therapies	-	-	-	-	-	-	-	-	-	-	-	$26.15M	$24.32M	$19.32M	$16.86M	$18.44M	$22.25M	$25.48M	-	-
Orthopedic Joint Preservation and Restoration Care	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$11.71M	$6.62M	$7.90M	-	-
Dermal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.25M	$417.00K
Orthobiologics	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$26.03M	$26.77M
Surgical	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.11M	$578.00K

Anika Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Joint Preservation and Restoration (83.42%), and Non-Orthopedic (16.58%).

Anika Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Europe	$22.21M	$19.40M	$21.72M	$20.64M	$19.58M
UNITED STATES	$70.06M	$82.45M	$123.13M	$119.15M	$113.83M

Anika Therapeutics's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (75.93%), and Europe (24.07%).

Quarterly Revenue by Country

Country	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Europe	$6.67M	$6.00M	$5.67M	$4.75M	$5.80M	$7.75M	$5.69M	$5.97M	$4.97M	$5.42M	$5.67M	$5.66M	$4.67M	$4.88M	$5.29M	$5.80M	$4.77M	$4.24M	$5.09M	$5.48M
UNITED STATES	$18.53M	$18.32M	$17.45M	$17.92M	$16.36M	$25.51M	$27.70M	$29.24M	$32.14M	$30.83M	$32.87M	$27.29M	$31.60M	$31.09M	$29.69M	$26.77M	$27.85M	$30.91M	$30.07M	$25.00M

Anika Therapeutics's latest quarterly revenue breakdown by geography, as of Mar 26: UNITED STATES (73.55%), and Europe (26.45%).

Anika Therapeutics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
LUCD	Lucid Diagnostics	$4.71B	$1.26B
ARAY	Accuray	$458.50M	$102.24M
QIPT	Quipt Home Medical	$245.36M	$82.24M
ANIK	Anika Therapeutics	$112.82M	$29.61M
OWLT	Owlet	$105.70M	$22.50M
LNSR	LENSAR	$58.44M	$13.43M
APYX	Apyx Medical	$52.10M	$12.42M
RPID	Rapid Micro Biosystems	$33.59M	$8.00M
MXCT	MaxCyte	$33.03M	$9.65M
AVR	Anteris Technologies Global	$1.91M	$494.00K
ANIX	Anixa Biosciences	-	-

ANIK Revenue FAQ

What is Anika Therapeutics’s yearly revenue?

Anika Therapeutics's yearly revenue for 2025 was $112.82M, representing a decrease of -5.91% compared to 2024. The company's yearly revenue for 2024 was $119.91M, representing a decrease of -0.73% compared to 2023. ANIK's yearly revenue for 2023 was $120.79M, representing an increase of 6.12% compared to 2022.

What is Anika Therapeutics’s quarterly revenue?

Anika Therapeutics's quarterly revenue for Q1 2026 was $29.61M, a -3.28% decrease from the previous quarter (Q4 2025), and a 13.16% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $30.62M, a 10.06% increase from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024). ANIK's quarterly revenue for Q3 2025 was $27.82M, a -1.42% decrease from the previous quarter (Q2 2025), and a -28.22% decrease year-over-year (Q3 2024).

What is Anika Therapeutics’s revenue growth rate?

Anika Therapeutics's revenue growth rate for the last 3 years (2023-2025) was -6.60%, and for the last 5 years (2021-2025) was -23.66%.

What are Anika Therapeutics’s revenue streams?

Anika Therapeutics's revenue streams in c 23 are Non-Orthopedic, and Joint Preservation and Restoration. Non-Orthopedic generated $9.86M in revenue, accounting 15.23% of the company's total revenue, up 24.02% year-over-year. Joint Preservation and Restoration generated $54.88M in revenue, accounting 84.77% of the company's total revenue, up 8.88% year-over-year.

What is Anika Therapeutics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Anika Therapeutics was Joint Preservation and Restoration. This segment made a revenue of $54.88M, representing 84.77% of the company's total revenue.